Skip to main content
letter
. 2020 Jun 16;33(4):e13501. doi: 10.1111/dth.13501

FIGURE 1.

FIGURE 1

Hypertensive patients assisted with angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) and cell entry of COVID‐19 mediated pathophysiological disturbance and cardiac injury